Comparing outcomes of clonidine and captopril in patients with hypertensive urgency: A randomized clinical trial
- PMID: 36818154
- PMCID: PMC9931607
- DOI: 10.48305/arya.v18i1.2146
Comparing outcomes of clonidine and captopril in patients with hypertensive urgency: A randomized clinical trial
Abstract
Background: Hypertension (HTN) is the second leading risk factor for death and disability. One fourth of healthcare in Eastern Europe and Central Asia is being spent on blood pressure (BP)-related diseases. An important situation in patients with high BP is hypertensive crisis (BP > 180/120 mmHg), which is divided to hypertensive emergency and urgency. Therefore, here, we decided to compare the effect of captopril and clonidine in patients with hypertensive urgencies, and their side effects.
Methods: This was a parallel-group randomized clinical trial. Patients, who referred to emergency ward with any symptoms of hypertensive crisis, underwent a careful history taking and clinical examination. Individuals with systolic BP (SBP) ≥ 180 mmHg or diastolic BP (DBP) ≥ 110 mmHg with no evidence of end organ damage were randomly assigned into two interventions, clonidine and captopril. 25% decrease in BP was considered as ideal relief.
Results: Regarding the duration of response to treatment drugs, patients who received clonidine relieved significantly faster than those who received captopril (P = 0.016). Moreover, the frequencies of side effects such as headache, dizziness/vertigo, dry mouth, and drowsiness in the clonidine group were significantly lower than captopril group (P < 0.05).
Conclusion: Patients in clonidine group relieved sooner and experienced fewer side effects. Therefore, this study suggests clonidine as a more effective therapeutic for hypertensive urgency compared with captopril.
Keywords: Captopril; Clonidine; High Blood Pressure Urgency; Hypertensive Crisis.
© 2022 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences.
Figures
Similar articles
-
Clonidine versus Captopril for Severe Postpartum Hypertension: A Randomized Controlled Trial.PLoS One. 2017 Jan 26;12(1):e0168124. doi: 10.1371/journal.pone.0168124. eCollection 2017. PLoS One. 2017. PMID: 28125624 Free PMC article. Clinical Trial.
-
[A comparison of the effect of oral captopril and nicardipine in hypertensive crisis].Tunis Med. 2008 Feb;86(2):150-4. Tunis Med. 2008. PMID: 18444532 Clinical Trial. French.
-
Comparison of midazolam versus captopril in patients with uncomplicated hypertensive urgency in emergency ward: Double-blind randomized clinical trial.ARYA Atheroscler. 2022 Jul;18(4):1-8. doi: 10.48305/arya.2022.26128. ARYA Atheroscler. 2022. PMID: 36817344 Free PMC article.
-
Comparative tolerability profile of hypertensive crisis treatments.Drug Saf. 1998 Aug;19(2):99-122. doi: 10.2165/00002018-199819020-00003. Drug Saf. 1998. PMID: 9704248 Review.
-
[Hypertensive urgencies and emergencies in pediatric patients].Pol Merkur Lekarski. 2021 Aug 16;49(292):306-310. Pol Merkur Lekarski. 2021. PMID: 34464374 Review. Polish.
References
-
- World Health Organization . A global brief on hypertension: Silent killer, global public health crisis: World Health Day 2016. Geneva, Switzerlans: WHO; 2016.
-
- Asareh Ar, Sharify N, Fayazi S, Haghighizadeh MH. White-coat effect on blood pressure measurement among visiting patients to Shiraz University Internal Clinic. Jundishapur Sci Med J. 2004;(40):24–30.
LinkOut - more resources
Full Text Sources